Aurélien MAZERAUD
Société Française d'Anesthésie et de Réanimation · Anesthésie - Réanimation GHU Paris - Neuro Sainte-Anne · Centre Hospitalier Sainte Anne
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aurélien MAZERAUD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:51 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07634172 · Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.Société Française d'Anesthésie et de Réanimation · not yet recruiting · Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit · study chair
- Ph3NCT07144956 · Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid HemorrhageCentre Hospitalier St Anne · not yet recruiting · Aneurysmal Subarachnoid Hemorrhage · principal investigator
- Ph3NCT04350580 · Polyvalent Immunoglobulin in COVID-19 Related ARdsCentre Hospitalier St Anne · completed · Acute Respiratory Distress Syndrome, COVID-19 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:51 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial.Lancet Respir Med · 202249 citationsRCR 3.2
- A randomized clinical trial to evaluate the effect of post-intensive care multidisciplinary consultations on mortality and the quality of life at 1 year.Intensive Care Med · 202449 citationsRCR 10.1
- Temporal stability of inflammatory subphenotypes of acute respiratory distress syndrome: 28-day insights from the ICAR trial.Anaesth Crit Care Pain Med · 202518 citationsRCR 4.3
- Valproic acid as adjuvant treatment for convulsive status epilepticus: a randomised clinical trial.Crit Care · 20236 citationsRCR 0.8